Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eve Courbon

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Canadian Journal of Hospital Pharmacy|June 28, 2014
[Not Available]Eve Courbon, Cynthia Tanguay, Denis Lebel, et al.
The Canadian Journal of Hospital Pharmacy|December 21, 2013
[Not Available]Eve Courbon, Isabelle Thériault-Dubé, Marylin Comelli, et al.
The Journal of Antimicrobial Chemotherapy|October 26, 2011
Unexpected atazanavir-associated biliary lithiasis in an HIV-infected patientEve Courbon, François Laylavoix, Cathia Soulié, et al.
Journal of Medical Virology|October 2, 2012
Switching to darunavir/ritonavir 800/100 mg once-daily containing regimen maintains virological control in fully suppressed pre-treated patients infected with HIV-1Jade Ghosn, Laurence Slama, Aziza Chermak, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Canadian Journal of Hospital Pharmacy|June 28, 2014
[Not Available]Eve Courbon, Cynthia Tanguay, Denis Lebel, et al.
The Canadian Journal of Hospital Pharmacy|December 21, 2013
[Not Available]Eve Courbon, Isabelle Thériault-Dubé, Marylin Comelli, et al.
The Journal of Antimicrobial Chemotherapy|October 26, 2011
Unexpected atazanavir-associated biliary lithiasis in an HIV-infected patientEve Courbon, François Laylavoix, Cathia Soulié, et al.
Journal of Medical Virology|October 2, 2012
Switching to darunavir/ritonavir 800/100 mg once-daily containing regimen maintains virological control in fully suppressed pre-treated patients infected with HIV-1Jade Ghosn, Laurence Slama, Aziza Chermak, et al.
Pageof 1